期刊文献+

糖皮质激素冲击和口服疗法对Graves眼病疗效比较 被引量:1

Comparison of the Curative Effect of Glucocorticoid Stosstherapy and Oral Administration in Treating Graves Ophthaimopathy
下载PDF
导出
摘要 目的比较糖皮质激素冲击和口服疗法对Graves眼病的疗效。方法初诊的Graves眼病28例,随机分为甲基强的松龙冲击治疗组和口服强的松组。治疗前,治疗10天和3个月后评价眼部体征及临床性活动评价(CAS),并对影响治疗效果的因素进行相关分析。结果甲基强的松龙治疗10天后CAS评分,软组织炎症评分明显下降,而强的松口服治疗无明显变化,但3个月疗程结束后两者CAS评分、软组织炎症、突眼度、眼裂宽度均有明显疗效,且无显著的统计学差异,CAS下降的程度与眼病病程明显负相关(r=0.317,P<0.05)。结论糖皮质激素冲击和口服疗法均对Grave眼病有明显效果,但前者起效较快。 Objective To compare the curative effects of glucocorticoid stesstherapy and oral administration in treating Graves ophthalmopathy. Methods 28 cases with Graves ophthahnopathy were randomly divided into 2 groups : stosstherapy group and oral administration group. The ocular condition and clinical activity scores(CAS) were evaluated before treatment, 10 days and 3 months after treatment. Results CAS and soft tissue inflammation decreased greatly 10 days after the methylprednisone(MP) treatment while no obvious change was found in oral adininistration group; however, at the end of the 3-month treatment, the curative effects in both groups were the same. The decrease of CAS was negatively correlated to the duration of eye disease( r = 0.317, P 〈 0.05 ). Conclusions Glucocorticoid Stosstherapy and oral administration are effective in treating Graves ophthahnopathy, but the former shows a quicker effect.
出处 《西南军医》 2007年第3期20-21,共2页 Journal of Military Surgeon in Southwest China
关键词 糖皮质激素 Grsves眼病 强的松 glucocorticoid Graves ophthalmopathy prednisone
  • 相关文献

参考文献2

二级参考文献28

  • 1Terwee C,Wakelkamp L,Tan S, et al. [J]. Eur J Endocrlnol, 2002,146 ( 6 ) :751-757.
  • 2Bednarczuk T, Hiromatsu Y, Fukutani T, et al.[J]. Eur J Endocrinol,2003,148( 1 ) :13-18.
  • 3Bahn RS. [J]. Endocrinol Metab Clin North Am,2000,29 ( 2 ) : 287-296.
  • 4Human PK. [J]. Cell Mol Life Sei, 2001,58:1301-1322.
  • 5Heufelder AE. [J]. Endocr Metab Disorder,2000,1 : 87-95.
  • 6Noh JY,Hamada N, Inoue Y,et al. [J] Thyroid,2000,9:809-813.
  • 7Hegedius L, Brix TH, Vestergaard P. [J]. J Endocrionl Invest, 2004,27 ( 3 ) : 265-271.
  • 8Bartalena L,Pinchera A, Marcocci C. [ J]. Endocrine Rev ,2000,21 ( 2 ) : 168-199.
  • 9Bartalena L, Marcocci C, Maria-Laura T. et al.[J]. Thyroid, 2002,12 ( 3 ) : 245-250.
  • 10Tsujino K,Hirota S,Hagiwara M,et al. [J]. J Radia Oncol Biol Phys,2000,48(3 ) :857-864.

共引文献30

同被引文献11

  • 1Bahn RS.Graves' ophthalmopathy [J].N Engl J Med,2010,362(8):726-738.
  • 2Marcocci C,Bartalena L,Panicucci M,et al.Orbital cobalt irradiation combined with retrobulbar or systemic corticos-teroids for Graves' ophthalmopathy:a comparative study [J].Clin Endocrinol(Oxf),1987,27(1):33-42.
  • 3Ponto KA,Kahaly GJ.Current management of endocrine orbitopathy [J].Med Klin(Munich),2008,103(10):717-730.
  • 4Bahn RS.High-dose intravenous glucocorticoid therapy for Graves' ophthalmopathy:where are we now? [J].Thyroid,2012,22(1):1-2.
  • 5Marcocci C,Bartalena L,Tanda ML,et al.Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy:results of a prospective,single-blind,randomized study [J].J Clin Endocrinol Metab,2001,86(8):3562-3567.
  • 6Ritva KM,Anni K,Eeva L,et al.High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroidassociated ophthalmopathy [J].Acta Ophthal-mol.Scand,2002,80(3):316-321.
  • 7Kahaly GJ,Pitz S,Hommel G,et al.Randomized,single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy [J].J Clin Endocrinol Metab,2005,90(9):5234-5240.
  • 8Aktaran S,Akarsu E,Kartal M,et al.Comparison of intra-venous methylprednisolone therapy vs.oral methylpred-nisolone therapy in patients with Graves' ophthalmopathy [J].Int J Clin Pract,2007,61(1):45-51.
  • 9Bartalena L,Baldeschi L,Dickinson AJ,et al.Consensus statement of the European group on Graves orbitopathy(EUGOGO)on management of Graves' orbitopathy [J].Thyroid,2008,18(2):333-346.
  • 10Perros P,Baldeschi L,Boboridis K,et al.A questionnaire survey on the management of Graves' orbitopathy in Eu-rope [J].Eur J Endocrinol,206,155(2):207-211.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部